Search Within

Jane Sze Yin Sui

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Solid Tumor Oncology Division (5)
  5. Thoracic Oncology (5)
  6. Weinberg Fellows (5)

More Groups

People
  1. Mark Kris (5)
  2. Gregory Riely (4)
  3. Alexander Drilon (3)
  4. Charles Rudin (3)
  5. Helena Yu (3)
  6. Marc Ladanyi (3)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Thoracic Oncology (2)
  3. European Journal of Cancer (1)
Publishers
  1. Elsevier Inc. (3)
  2. American Society of Clinical Oncology (2)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets)
    Meeting Abstract

    Sui, J. S. Y.; Wilcox, J.; Tischfield, S.; Choudhury, N. J.; Riely, G. J.; Kris, M. G.; Boire, A. A.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Journal Article

    Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and mutational landscape of BRAF(V600E)-mutant non-small cell lung carcinoma
    Meeting Abstract

    Sui, J. S. Y.; Ladanyi, M.; Rudin, C. M.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Offin, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save